发明公开
- 专利标题： COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER
-
申请号： EP22201152.0申请日： 2014-02-18
-
公开(公告)号： EP4177273A1公开(公告)日： 2023-05-10
- 发明人: SAHIN, Ugur , TÜRECI, Özlem , MITNACHT-KRAUS, Rita , WÖLL, Stefan , JACOBS, Stefan , HEINZ, Cornelia
- 申请人： Astellas Pharma Inc. , TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH
- 申请人地址： JP Chuo-ku Tokyo 103-8411 5-1, Nihonbashi-Honcho 2-Chome; DE 55131 Mainz Freiligrathstrasse 12
- 代理机构： Schnappauf, Georg
- 优先权： WOPCT/EP2013/000505 20130220
- 主分类号： C07K16/30
- IPC分类号： C07K16/30 ; A61K39/00 ; A61K39/395 ; C07K16/28
摘要：
The present invention provides a combination therapy for effectively treating and/or preventing diseases associated with cells expressing CLDN18.2, including cancer diseases such as pancreatic cancer and metastases thereof.
信息查询
